Image

Akoustis Applied sciences, Inc. (AKTS) Q2 2024 Earnings Name Transcript

Akoustis Applied sciences, Inc. (NASDAQ:AKTS) Q2 2024 Outcomes Earnings Convention Name February 13, 2024 8:00 AM ET

Firm Members

Kenneth Boller – Chief Monetary Officer

Jeffrey Shealy – Founder and Chief Govt Officer

David Aichele – Govt Vice President of Enterprise Improvement

Convention Name Members

Anthony Stoss – Craig-Hallum Capital Group

Craig Ellis – B. Riley Securities

Suji Desilva – ROTH-MKM

Operator

Good day, girls and gents, and welcome to the Akoustis Applied sciences Fiscal 2024 Second Quarter Convention Name. As a reminder, this convention is being recorded. On the conclusion of the corporate’s presentation, Akoustis administration will take questions. [Operator Instructions] A replay of the decision shall be accessible on the Investor Relations part of the Akoustis web site. Thanks. You might start.

Kenneth Boller

Thanks, operator. And good morning to everybody on the decision. Welcome to Akoustis’ second quarter fiscal 2024 convention name. I am Ken Boller, CFO. I am joined at present by our Founder and CEO, Jeff Shealy, and EVP of Enterprise Improvement, Dave Aichele.

Earlier than we start, please notice that at present’s presentation consists of forward-looking statements about our enterprise outlook. All statements apart from statements of historic information included on this convention name, corresponding to expectations concerning our methods and operations, together with the timing and prospects of product improvement and buyer orders and design wins; doable collaborative or partnering relationships; litigation issues; and anticipated monetary and working outcomes are forward-looking statements.

Such forward-looking statements are predictions primarily based on the corporate’s expectations as of at present and are topic to quite a few dangers and uncertainties. The corporate and our administration crew assume no obligation to replace any forward-looking statements made on at present’s name. Our SEC filings point out essential components that might trigger precise outcomes to vary materially. Please confer with our newest Kind 10-Okay and Kind 10-Q filed with the SEC to get a greater understanding

SHARE THIS POST